SCHEMBL22688574

SCHEMBL22688574

CNCCCN(CCCNC(=O)C(F)(F)F)C(=O)C(F)(F)F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA14 Q9ULX7 2/20 0.56
ALDH1A1 P00352 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
POLB P06746 2/20 0.53
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
EPHX1 P07099 1/20 0.49
CA3 P07451 2/20 0.47
CA5A P35218 2/20 0.47
CA5B Q9Y2D0 2/20 0.47
CA12 O43570 1/20 0.47
CA2 P00918 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
NPC1 O15118 1/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
GSTO1 P78417 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3138315 0.90 CA14 (0.62) CA14ALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL21761825 0.85 CA3 (0.68) CA14ALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL3134521 0.83 CA14 (0.52) CA14ALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL21762356 0.83 CA3 (0.69) CA14ALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL4147505 0.82 ALDH1A1 (0.71) CA14ALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL10650040 0.82 ALDH1A1 (0.78) CA14ALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL11316197 0.81 EPHX1 (0.54) CA14ALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL16221898 0.81 MEN1 (0.79) CA14ALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL3134298 0.79 CA14 (0.48) CA14ALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL24119693 0.78 ALDH1A1 (0.59) CA14ALDH1A1SMN1; SMN2POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11660347-B2 Nucleic acid, composition and conjugate containing same, preparation method, and use thereof Suzhou Ribo Life Science Co., Ltd. (CN) 2023-05-30 US disclosed
US-20200360522-A1 NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING SAME, PREPARATION METHOD, AND USE THEREOF Suzhou Ribo Life Science Co., Ltd. (CN) 2020-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11660347-B2 Nucleic acid, composition and conjugate containing same, preparation method, and use thereof APOB, C1QBP, APOL1 CA14 4194/4885ALDH1A1 3395/4885SMN1; SMN2 1662/4885
US-20200360522-A1 NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING SAME, PREPARATION METHOD, AND USE THEREOF APOB, C1QBP, APOL1 CA14 4194/4885ALDH1A1 3395/4885SMN1; SMN2 1662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.